Low-dose growth hormone hypothesized to reduce visceral fat in HIV lipodystrophy patients
Physiologic Growth Hormone Effects in HIV Lipodystrophy
Abstract
Low-dose growth hormone was hypothesized to reduce visceral fat in HIV lipodystrophy patients, with secondary endpoints including IGF-1, glucose, and lipids.